NFA
IMUX icon

Nationwide Fund Advisors’s Immunic IMUX Stock Holding History

Nationwide Fund Advisors’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-36
Closed -$58K – 3227
2017
Q1 		$58K Hold
36
– – ﹤0.01% 2957
2016
Q4 		$63K Hold
36
– – ﹤0.01% 2971
2016
Q3 		$88K Hold
36
– – ﹤0.01% 2932
2016
Q2 		$89K Buy
36
+3
+9% +$9.86K ﹤0.01% 2952
2016
Q1 		$120K Hold
33
– – ﹤0.01% 2745
2015
Q4 		$154K Buy
33
+6
+22% +$19.6K ﹤0.01% 2666
2015
Q3 		$44K Sell
27
-38
-58% -$190K ﹤0.01% 3038
2015
Q2 		$546K Buy
65
+18
+38% +$172K ﹤0.01% 2198
2015
Q1 		$470K Hold
47
– – ﹤0.01% 2263
2014
Q4 		$464K Buy
47
+37
+370% +$285K ﹤0.01% 2225
2014
Q3 		$82K Hold
10
– – ﹤0.01% 3036
2014
Q2 		$107K Buy
+10
New +$70.2K ﹤0.01% 3005

Other funds holding IMUX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TP
Truvvo Partners New York $5.22M AUM 13.74% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

Nationwide Fund Advisors's IMUX Position: Q2 2017 in Review

Nationwide Fund Advisors sold out of Immunic (IMUX) in Q2 2017, closing a stake of 36 shares — an estimated $58K sold.

Nationwide Fund Advisors first reported a position in IMUX in Q2 2014 and held it in 12 quarters. The position peaked at $546K in Q2 2015. 50 funds tracked by Wall St. Rank hold IMUX as of Q2 2017.

  • Nationwide Fund Advisors reported no remaining Immunic position as of Q2 2017 after selling out during the quarter.
  • Nationwide Fund Advisors sold 36 Immunic shares in Q2 2017, an estimated $58K.
  • Nationwide Fund Advisors first reported a position in Immunic in Q2 2014 and held it in 12 quarters.
  • Nationwide Fund Advisors's Immunic position peaked at $546K in Q2 2015.
  • 50 funds tracked by Wall St. Rank held Immunic as of Q2 2017.

Based on Nationwide Fund Advisors's 13F filing for Q2 2017, filed 10 Aug 2017.